Yoda Pharmaceuticals Inc. (TPEX:7829)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
57.10
+5.40 (10.44%)
At close: Feb 26, 2026
Market Cap 4.53B
Revenue (ttm) n/a
Net Income (ttm) -315.73M
Shares Out 79.39M
EPS (ttm) -4.35
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 150,639
Average Volume 273,297
Open 51.70
Previous Close 51.70
Day's Range 50.90 - 57.10
52-Week Range 32.65 - 77.60
Beta n/a
RSI 44.90
Earnings Date Apr 29, 2026

About Yoda Pharmaceuticals

Yoda Pharmaceuticals Inc., an AI-driven company, focuses on development of drugs targeting central nervous system disorders. The company’s flagship drug, YA-101 is in Phase 2 clinical trial for the treatment of multiple system atrophy. It is also involved in the development pipeline includes drugs in the field of neurological and psychiatric disorders and cerebrovascular diseases, targeting conditions, such as schizophrenia, Alzheimer's disease, Parkinson‘s disease, Autism, ischemic stroke, and traumatic brain injury. Yoda Pharmaceuticals Inc. ... [Read more]

Industry Pharmaceutical Preparations
Founded 2019
Country Cayman Islands
Stock Exchange Taipei Exchange
Ticker Symbol 7829
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.